PFAS-free fume suppressant for hexavalent-chromium plating baths

Hexavalent-chromium plating is a $1-3B global surface-finishing segment facing a forced regulatory substitution in its fume-control chemistry. The suppressants platers currently use — 6:2 fluorotelomer sulfonate and related PFAS-based wetting agents — are being eliminated by the ECHA universal-PFAS restriction, the EU Cr(VI) restriction transition, and the California Air Resources Board hard-chrome phase-out (functional compliance deadline 2039). No other regulatory category so precisely targets a single chemistry class while leaving the underlying industrial process (hard-chrome plating) temporarily still permitted. Every active plating line must reformulate its bath chemistry, and there is no PFAS-free fume suppressant on the market that demonstrably matches fluorotelomer mist-suppression performance. This asset, part of Lattice Graph's PFAS-free dielectric and process fluids portfolio, covers a composition designed to fill exactly that gap: an alpha-hydrogen-free branched alkane sulfonate surfactant package that reaches a surface tension at or below 33 mN/m in active chromic acid bath conditions without fluorine. The structural insight is that conventional hydrocarbon surfactants degrade in hot chromic acid through radical alpha-C-H abstraction; by eliminating all abstractable alpha hydrogens at the sulfonate-bearing carbon, the molecule blocks that degradation pathway and can sustain active surface tension over bath life. The composition is claimed head-to-head against 6:2 fluorotelomer sulfonate, which defines the performance bar the market will require before adoption.

The bath formulation covered by this composition consists of chromic anhydride (CrO3) at 180-300 g/L with sulfuric acid at 1.8-4.0 g/L as the conventional electroplating base, to which the novel package is added: an alpha-hydrogen-free branched alkane sulfonate at 50-150 mg/L as the active fume suppressant, a phosphonate stabilizer (either carbon-phosphonate or aminomethylene-phosphonate structural class) at 10-30 mg/L, and an amphoteric foam moderator at 15-30 mg/L. Total organofluorine in the finished bath is below 1 mg/L. The functional performance target is surface tension at or below 33 mN/m measured by tensiometer, or equivalently at or below 40 dyn/cm by stalagmometer — the threshold that governs suppression of aerosolized Cr(VI) mist. The materials-science core of the design is oxidative survival. Hot chromic acid (a powerful oxidizing environment) degrades conventional alkane sulfonates through radical abstraction of the alpha C-H bonds adjacent to the sulfonate group, destroying the surfactant and its surface-active function over bath life. The structural solution is to bond the sulfonate directly to a fully substituted carbon (quaternary or gem-dialkyl) carrying no hydrogen at the alpha position, which closes the radical abstraction pathway. The specific structural genera covered include sodium 2,2-dimethyl-hexadecanesulfonate (a C16 alpha,alpha-dimethyl species), sodium 2,4,6-trimethyl-2-sulfonatohexane, a fully substituted tertiary alkanesulfonate sub-genus, and a gem-dialkyl beta-blocked primary sub-genus. The phosphonate stabilizer prevents complexation side reactions, and the amphoteric foam moderator controls foam without competing with the primary surfactant function. Computational characterization was performed using two complementary quantum-chemical and simulation approaches. Coarse-grained interfacial molecular dynamics was used to model surfactant surface excess at the bath-air interface, confirming that alpha-H-free branched species achieve adsorption geometries consistent with the target surface-tension endpoint. Separately, semiempirical xTB calculations directly compared radical-formation energies for alpha-H-free versus linear alkane sulfonates, providing a quantitative energy-gap estimate for the oxidative-resistance mechanism. An additional xTB property screen mapped candidate structures against the surface-tension and stability targets. This is a non-crystalline molecular system, so crystallographic stability metrics (phonon consensus, imaginary modes) are not the relevant validation frame; the validation path is instead the oxidative-aging bench experiment and the surfactant property screen, with the computational results providing mechanistic grounding and candidate prioritization ahead of bench work. The mechanism is further anchored in published radical-oxidation chemistry literature (Kwong 2018, ACS Earth and Space Chemistry).

We estimate the total addressable market at $1-3 billion across the hexavalent-chromium surface-finishing segment — hard-chrome plating, anodizing, etching, and conversion coating. This is an estimate based on installed global plating line counts and current additive spend per line; precision depends on the fraction of lines that adopt a non-PFAS suppressant before the Cr(VI) process itself phases down. The primary commercial pathway is licensing to plating-chemistry formulators who manufacture and sell bath additive packages. A composition patent supports running royalties structured per kilogram of specialty surfactant sold into the bath, or alternatively per bath volume or as a revenue-sharing arrangement with an exclusive formulator. A supply-plus-royalty model is also viable if the patentee or a licensed partner manufactures the alpha-H-free surfactant directly, capturing margin on a specialty synthesis rather than only a royalty on downstream volume. The regulatory forcing function is unusually precise. The ECHA universal-PFAS restriction targets fluorotelomer sulfonates specifically; platers do not have the option of arguing for continued use of 6:2 FTS on performance grounds. The CARB hard-chrome phase-out creates a U.S. compliance deadline, and EU Cr(VI) authorizations are under restriction review. These are independent regulatory tracks that together cover the majority of global hard-chrome capacity, meaning adoption is not discretionary — it is a compliance requirement for operators who continue Cr(VI) plating. The addressable base is therefore the entire installed population of hexavalent-chromium lines still operating in 2026-2039, which is a large and captive substitution market. Field-of-use licensing adds commercial flexibility. The same alpha-H-free surfactant chemistry is relevant to chromic acid anodizing, etching, and conversion coating in addition to plating, and separate licenses across these segments can allow the owner to monetize multiple formulators without territorial conflict. Early formulator partnerships are especially valuable because qualification cycles for bath additives (including mist-suppression verification and environmental screening) typically require 12-24 months ahead of a compliance deadline, giving a head start to whoever secures a licensed position first.

PFAS-free fume suppressant matching 6:2-FTS surface-tension/mist performance with TOF <1 mg/L

aliphatic sulfonate bonded directly to fully-substituted/gem-dialkyl carbon with no abstractable alpha-H; no betaine, no polyorganosiloxane required

The primary licensees are plating-chemistry formulators — companies that manufacture and distribute bath additive packages to hard-chrome plating operations. These buyers have direct commercial incentive to secure a qualified PFAS-free fume-suppressant package ahead of their competitors before regulatory deadlines, and a composition license with a running royalty on additive volume or an exclusive supply arrangement fits their business model. Large specialty-chemical companies with existing hard-chrome additive product lines (such as MacDermid Enthone, Atotech/MKS, or similar players) are the most natural commercial partners, as they already have the sales channels, technical service infrastructure, and regulatory experience to qualify and distribute a new bath additive. Secondary buyers include specialty surfactant manufacturers capable of synthesizing alpha-H-free branched alkanesulfonates, who may be interested in a manufacturing-plus-license position, and aerospace or industrial hard-chrome finishing groups facing their own internal PFAS phase-down mandates ahead of regulatory deadlines. The regulatory clock creates an asymmetry that favors early engagement: qualification cycles for new bath additives typically require 12-24 months of internal testing and regulatory documentation, meaning a formulator who licenses and begins qualification in 2026 has a meaningful lead over one who waits. The CARB 2039 functional deadline sounds distant, but process qualification, customer qualification, and regulatory filing timelines consume most of that runway.

The most material risk is that the three open bench-validation gates remain unconfirmed. The oxidative-resistance mechanism is well-grounded in published chemistry and supported computationally, but the 168-hour hot-chromic-acid retention experiment is the proof that the molecule actually survives at the concentrations and temperatures of a production plating bath. If active-surfactant concentration degrades significantly over the test period, the whole design hypothesis fails. Mist-suppression parity against 6:2 fluorotelomer sulfonate and acceptable aquatic toxicity are also unconfirmed. A buyer funding the next phase needs to budget for this bench campaign — it is the single highest-priority expenditure before commercial deployment. Freedom-to-operate is narrow, and specifically the relationship to US 12,173,422 requires a formal clearance opinion. The alpha-H-free aliphatic sulfonate genus must be confirmed both non-obvious in view of the radical-oxidation literature and structurally clear of the betaine-siloxane claims. There is also a strategic risk inherent to the market itself: the CARB hard-chrome phase-out and EU Cr(VI) restrictions that drive demand for this suppressant are also gradually shrinking the hexavalent-chromium plating market. The suppressant's commercial window is therefore bounded — it is valuable precisely because it is the right substitute for the transition period, not a permanent platform. Finally, any new surfactant entering the plating-bath additive market requires its own environmental and worker-safety qualification, which adds time and cost even if the toxicity profile proves favorable.